University of Oxford NDORMS Revenue and Competitors

Oxford, UK

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • University of Oxford NDORMS's estimated annual revenue is currently $13M per year.(i)
  • University of Oxford NDORMS's estimated revenue per employee is $102,000

Employee Data

  • University of Oxford NDORMS has 127 Employees.(i)
  • University of Oxford NDORMS grew their employee count by 6% last year.

University of Oxford NDORMS's People

NameTitleEmail/Phone
1
Outreach and Public Engagement OfficerReveal Email/Phone
2
Human Resources OfficerReveal Email/Phone
3
Laboratory Manager - Dakin GroupReveal Email/Phone
4
Research Grants Deputy ManagerReveal Email/Phone
5
Finance ManagerReveal Email/Phone
6
Clinical Trial ManagerReveal Email/Phone
7
Clinical Trial Manager for Covid studiesReveal Email/Phone
8
Researcher PHD StudentReveal Email/Phone
9
Associate ProfessorReveal Email/Phone
10
Medical Device ResearcherReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.1M69-13%$16.5MN/A
#2
$264.2M1850-1%N/AN/A
#3
$51.9M401-10%$12.6MN/A
#4
$22.5M205-39%$63.8MN/A
#5
$1.1M21-19%$781.7KN/A
#6
$21.3M19033%N/AN/A
#7
$11.9M11710%N/AN/A
#8
$3.8M46-10%N/AN/A
#9
$8.8M86-16%N/AN/A
#10
$2.5M31-40%N/AN/A
Add Company

What Is University of Oxford NDORMS?

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is a multi-disciplinary department focusing on musculoskeletal diseases, from bench to bedside. Our mission is to discover the causes of musculoskeletal conditions and deliver excellent and innovative translational research that improves people's quality of life.

keywords:N/A

N/A

Total Funding

127

Number of Employees

$13M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

University of Oxford NDORMS News

2022-04-06 - Liposomal bupivacaine found to be no more effective than ...

Researchers at the Universities of Oxford and Leeds developed the ... at NDORMS said: "We found that liposomal bupivacaine injected at the...

2022-03-22 - Association between covid-19 vaccination, SARS-CoV-2 ...

... to: D Prieto-Alhambra daniel.prietoalhambra ndorms.ox.ac.uk (or ... vector vaccines: ChAdOx1 nCoV-19 (Oxford-AstraZeneca) and Ad.26.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.6M1284%N/A
#2
$13.2M129108%N/A
#3
$13.5M132-13%$169.2M
#4
$38.3M1326%N/A
#5
$29.3M1334%N/A